Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$8.35 - $21.89 $1.67 Million - $4.38 Million
-200,000 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$25.61 - $41.78 $9.71 Million - $15.8 Million
-379,116 Reduced 65.46%
200,000 $6.25 Million
Q3 2020

Nov 12, 2020

BUY
$11.21 - $13.82 $104,028 - $128,249
9,280 Added 1.63%
579,116 $6.8 Million
Q2 2020

Aug 12, 2020

BUY
$9.8 - $12.77 $5.52 Million - $7.2 Million
563,588 Added 9020.29%
569,836 $6.5 Million
Q1 2020

May 14, 2020

SELL
$8.78 - $18.6 $4.86 Million - $10.3 Million
-553,588 Reduced 98.88%
6,248 $69,000
Q1 2020

May 14, 2020

BUY
$8.78 - $18.6 $1.92 Million - $4.06 Million
218,200 Added 63.87%
559,836 $6.25 Million
Q4 2019

Feb 14, 2020

BUY
$13.12 - $17.06 $4.48 Million - $5.83 Million
341,636 New
341,636 $5.46 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $274M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Bleichroeder LP Portfolio

Follow Bleichroeder LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

News

Stay updated on Bleichroeder LP with notifications on news.